09:46 AM EST - XORTX Therapeutics Inc : Announced the grant of Orphan Drug Designation for oxypurinol – “orphan-drug designation request of oxypurinol is granted for treatment of autosomal dominant polycystic kidney disease”. XORTX Therapeutics Inc
shares V.XRTX are trading up $0.01 at $1.03.
